The purpose of the present study was to determine the immunochemical properties of apolipoprotein (apo) B-100 associated with low density lipoprotein (LDL) in relation to lipid and apolipoprotein composition. LDLs were isolated by sequential ultracentrifugation (1.019<rf< 1.050 g/mL) from two healthy volunteers and 21 dyslipidemic patients to obtain heterogeneous samples of LDL. Lipid (free cholesterol, cholesteryl esters, triglycerides, and phospholipids) and apolipoprotein contents (apo B, apo C-III, apo E) were determined in each LDL sample. Immunoreactivities of apo B were tested in solid-phase competitive-binding radioimmunoassays using seven monoclonal anti-LDL antibodies that reacted with defined epitopes of apo B-100. The relation between lipid and/or protein variables and the immunoreactivity of apo B was evaluated by successive use of Spearman's rank simple correlation, partial correlation, and canonical correlation analyses. The canonical correlation analysis showed that apo B-100 immunoreactivity on LDL is highly dependent on lipid and apolipoprotein composition simultaneously. The results confirmed the influence of surface and core lipids on the expression of the apo B-100 epitopes, independent of their location on the molecule. However, the lipid requirement of LDL strongly influences the expression of epitopes mapped in the LDL receptor-recognition domain. In contrast to apo E, apo C-III does not seem to influence the expression of the apo B-100 epitopes in the LDL range studied. To understand the structural organization (chemical composition and immunoaccessibility) of apo B-100 in LDL and therefore its potential atherogenicity, it is necessary to keep in mind that LDL is an indissociable association of lipids plus apolipoproteins and that both parameters simultaneously act to maintain apo B-100 in its spatial disposition. ( implicated in the development of atherosclerosis, and the concentration of LDL cholesterol in plasma is highly correlated with the incidence of coronary heart disease. 1 LDLs are the major carriers of cholesterol and cholesteryl esters in human plasma. These particles are spherical and are constituted of a neutral lipid core (mainly composed of cholesteryl esters) surrounded by a polar surface shell of phospholipids, unesterified cholesterol, and protein.
L ow density lipoproteins (LDLs) have long been implicated in the development of atherosclerosis, and the concentration of LDL cholesterol in plasma is highly correlated with the incidence of coronary heart disease. 1 LDLs are the major carriers of cholesterol and cholesteryl esters in human plasma. These particles are spherical and are constituted of a neutral lipid core (mainly composed of cholesteryl esters) surrounded by a polar surface shell of phospholipids, unesterified cholesterol, and protein.
2 Apolipoprotein (apo) B-100 is the major protein constituent of LDL and is the ligand recognized by the apo B:E receptor. 3 Interactions between LDL and its receptor depend on the integrity of both the receptor protein and the recognition domain of apo B-100. 4 Several studies have demonstrated that, in fact, LDLs are a heterogeneous collection of particles with distinct physical and chemical characteristics. LDL composition might differ, depending on different states with metabolic, clinical, pharmacological, or dietary origins. These alterations in composition and, thus, in conformation may induce perturbed catabolism. 5 - 8 Immunochemical methods allow the detection of physicochemical changes of LDL-apo B-100 and their localization on the apo-B molecule.
However, the lipoprotein components responsible for maintaining epitopes in a given conformation remain unclear. Many results confirm the importance of the lipid moiety of LDL in keeping the conformation of apo B, 9 -11 but it is undisputable that the protein moiety also plays an important role in this. 1213 The purpose of our study was to search for potential conformational alterations of LDL-apo B-100 linked to the lipidic and/or apolipoprotein environment.
Therefore, we have used three tools to clarify the cause of immunochemical heterogeneity of apo B-100: 1) LDL obtained from a wide variety of dyslipidemic patients, thus exhibiting a very large heterogeneity in chemical composition; 2) seven monoclonal antibodies (MAbs) that have been well characterized and whose epitopes are distributed all along the apo B molecule; and 3) a canonical correlation analysis permitting the linkage of LDL composition and apo B-100 epitope expression. The canonical correlation analysis was an original statistical approach to take into account both lipid and apolipoprotein components that act in concert to determine the structural heterogeneity of LDL. 
Methods

Subjects
The study subjects consisted of two healthy normal volunteers and 21 dyslipidemic patients (primary and secondary dyslipidemia). The biochemical characteristics of the subjects are summarized in Table 1 .
LDL Isolation
Venous blood was drawn after a 12-hour overnight fast from healthy donors or patients. Plasma was separated at 3,000 rpm within 3 hours. Samples were kept at 4°C in the presence of preservatives for no longer than 3 days. These additives (and their final concentrations) were as follows (mM): EDTA 0.27, cis-aminocaproic acid 0.9, chloramphenicol 0.6, and glutathione 0.3. LDLs were then obtained by sequential ultracentrifugation in a Beckman 50.2 Ti rotor at a density between 1.019 and 1.050 g/mL.
14 This density range was chosen because there is thus no contamination by very low density lipoprotein (VLDL) and lipoprotein a. Isolated LDLs were dialyzed against phosphate-buffered isotonic saline buffer (PBS) containing 10 /xM EDTA. The purity of LDL was assessed by nondenaturing discontinuous gradient polyacrylamide gel electrophoresis (PAGE) of the individual samples. 15 The apolipoprotein contents of LDL were analyzed by gradient (3-25%) sodium dodecyl sulfate-PAGE (SDS-PAGE) under reducing conditions using /3-mercaptoethanol. 16 From a pool of fresh normal plasma that also contained preservatives as above, an LDL standard batch was likewise ultracentrifugally purified. It was sterilized by filtration through a 0.2-/xm filter, dialyzed, and stored at 4°C in sterile aliquots under nitrogen in the dark. No protein degradation by proteolytic or oxidative processes occurred throughout the 3 months of the study, as confirmed by the lack of apo B fragmentation after SDS-PAGE on a 4-15% gradient. 17 
Iodination of LDLs
Some aliquots of LDL standard were radioiodinated with sodium iodide-125 according to the procedure of McFarlane 18 as modified by Bilheimer et al.
19
l25 I-labeled LDL preparations used in immunoassays were kept in tightly capped vials in the dark under nitrogen at 4°C for no longer than 2 weeks. We needed to use three different preparations to perform the study. The mean specific activity of 125 I-labeled LDL was 500 cpm/ng protein, and in each preparation, more than 90% of the radioactivity was precipitable by 10% trichloroacetic acid.
Quantification of Lipids and Apolipoproteins
All the following determinations were performed on plasma and LDL preparations of the individual samples. Total cholesterol, triglycerides, and phospholipids were automatically measured by enzymatic methods adapted to a Hitachi 705 analyzer (Boehringer Mannheim, Mannheim, FRG). Free cholesterol was determined manually with a modified Boehringer Mannheim kit in which cholesterol ester hydrolase was omitted. The between-assay coefficients of variation for the lipids were below 2%. Cholesteryl ester content was calculated as 1.68x(total cholesterol-free cholesterol).
Apo B, apo C-III, and apo E were quantified by established immunoenzymatic assays with coefficients of variation of less than 7%. 20 - 22 On 10 different LDL preparations, we have proved the excellent accuracy of the apo B immunoassay by comparing the results with those provided when assaying the content of apo B before and after precipitating the protein with isopropanol. 23 LDL protein content was assessed by the method of Lowry et al, 24 with bovine serum albumin (BSA) used as a standard.
Monoclonal Anti-Apo B Antibodies
Seven anti-human LDL MAbs (Bl, B4, BL3, BL7, DA7, BA11, and BL5) were produced in rats or mice by using intact LDLs as immunogens as previously described. 2526 MAb Bl defines an epitope on the aminoterminal region of apo B-100 (between amino acid residues 405 and 539); the epitope for B4 is located in the thrombin cleavage fragment T3 between residues 1,854 and 1,878; and MAbs BL3 and BL7 recognize epitopes situated at residues 4,355 and 2,331, respectively. 27 The assignment of MAb DA7 epitope is provisional, and two different fusion proteins can react with it. Nevertheless, it seems to be located close to the Af-terminal part of the receptor-binding domain (authors' unpublished observations). MAb BAH interferes with the binding of human LDL to the apo B:E receptor and, in fact, competes with antibodies 5E11, 3A8, 3A10, and MB47, whose epitopes span residue 3,506.
2527 BL5 fails to compete with any other antibody or fusion protein, suggesting that it recognizes only conformationally expressed epitopes. 27 
Solid-Phase Radioimmunoassay
To determine the immunoreactivity of LDL preparations, we performed a solid-phase radioimmunoassay in which the lipoproteins were assayed in competitive displacement assays on microtiter plates (Costar Corp., Cambridge, Mass.) as follows. Microtiter wells were coated with 100 ;u,L MAb solution (20 fig/mL PBS) overnight at room temperature. Wells were then washed and saturated as previously described. 25 Serial triplicate dilutions of competitors (each LDL preparation and LDL standard, expressed as protein apo B content) were added in 50 /xL PBS-BSA together with a constant amount of After incubation overnight at room temperature, the wells were washed and counted. B/BO ratios (where B and BO are specific counts per minute bound in the presence and absence of competitors, respectively) versus lipoprotein concentrations were plotted, and the apparent apo B contents (number of epitopes expressed) were calculated from competitive displacement curves. The results were expressed as a percentage of the standard, to which an arbitrary expression for each epitope was assigned as 100%. So, a percentage value below 100 indicates that fewer LDLs are needed to achieve the same degree of displacement of the labeled LDL standard ligand and reflects a better accessibility of the measured epitope.
The displacement curves were then linearized by logit-log transformation of the data, 28 - 29 and slopes were calculated. They correspond to the apparent affinity of the different LDL preparations for each antibody and yield the degree of heterogeneity of the LDL.
The reproducibility of the procedure was assessed from LDL standard data; the coefficients of variation between assays were approximately 10%.
Statistical Analysis
The correlations between each lipid and protein variable (as represented by free cholesterol, cholesteryl esters, triglycerides, phospholipids, apo B, apo C-III, and apo E) and the immunoreactivity of LDL (as represented by the apparent apo B content and affinity) were first tested by performing Spearman's rank simple correlation analysis.
If more than one lipid and/or protein variable was significantly correlated with one of the variables related to the immunoreactivity of LDL, the existence of a direct relation was then searched by a partial correlation analysis, taking into account only one biochemical variable at a time and removing the effects of other regressors by adjusting them to a constant level.
In a third step, we considered the lipid and protein data together as one group of variables and used a canonical correlation analysis 30 to determine a relation between this group of variables and the immunoreactivity of LDL. Table 2 presents the chemical composition of the LDL preparations. Results are expressed as mean±SD, range, and median values. For cholesterol, phospholipids, proteins, and apo B, no major displacement exists between the mean and median values, thus suggesting a gaussian distribution for these parameters. Triglycerides, apo C-III, and apo E median levels are shifted toward lower values than mean data, indicating some very different elevated values in certain LDL preparations. The results point out the large heterogeneity expected in chemical composition of the LDL preparations.
Results
The data regarding the immunochemical reactivity of LDL preparations are compiled in Table 3 . The slopes of the linearized displacement curves exhibit a gaussian distribution for apparent apo B content measured with MAbs Bl, DA7, BL3, BL5, and BL7. The median expression of epitopes specifically recognized by MAbs B4 and BA11 is displaced toward lower percentage values than the mean data. This reflects a very poor The apparent apolipoprotein (apo) B contents and slopes express the average number of epitopes accessible on the low density lipoprotein (LDL) preparations and the affinity of the different LDL preparations for the monoclonal antibodies (MAbs), respectively (described in "Methods").
*p<0.Q5, tp<0.01, $p<0.001.
B epitopes in a more accessible way than the LDL standard; in some others, in contrast, apo B epitopes are "buried" and less immunoreactive. The accessibility of epitopes recognized by MAb BL5 seems less altered than the others and even appears enhanced as compared with the LDL standard. By Spearman's rank simple correlation analysis, some significant correlations have appeared between the immunoreactivity of LDL preparations and some lipid or protein variables.
Since we had obtained different groups of more than two variables that were correlated with the same immunochemical criterion, we searched for a direct relation between each isolated variable and the immunochemical parameter by a partial correlation analysis. Only the significant and direct correlations that have been so retained are presented in Table 4 . A negative correlation coefficient between any apparent apo B content and any lipid or protein variable indicates that the higher the level of one of these variables, the more important is the apparent apo B content and, therefore, the more accessible is the epitope that is recognized by the MAb, and vice versa. In contrast, a positive correlation coefficient between any affinity data of LDL for MAbs (expressed by slopes) and any lipid or protein variable represents a positive relation between the two considered parameters, and vice versa.
In the canonical correlation analysis, we considered LDLs as particles that consist of linear indissociable components, lipids, and apolipoproteins. In this approach, the canonical variable is aiinear combination of the relevant lipid and/or protein parameters. In Table 5 , we report 1) the immunochemical criteria that have been found to be significantly dependent on the chemical environment of LDL, 2) the different parameters that determine the canonical variable, 3) the correlation coefficient of each variable with the canonical variable, 4) the canonical correlation coefficient that exists between the canonical variable and the immunochemical data, 5) the significance level of this canonical correlation coefficient, and 6) the equation of the canonical variable. Because all of the variables are not measured in the same units, standardized coefficients rather than raw coefficients are reported in the equation; these standardized coefficients can then be interpreted. For example, the first canonical variable for the apparent apo B content measured with MAb DA7 is a weighted difference of apo E (0.75) and triglyceride (-0.62) levels, with about the same emphasis on both variables. The correlations between apo E and triglycerides and the canonical variable [Can (E, TG), where E is apo E content and TG is triglyceride content] are 0.78 and -0.65, respectively. The coefficient of each variable and its correlation with the canonical variable have the same sign (positive for apo E and negative for triglycerides). So, neither apo E nor triglyceride acts as a suppressor variable. For another example, the canonical correlation between the apparent apo B content measured with MAb BA11 and the canonical variable [Can (FC, CE, TG)=2.25FC+2.68CE+3.47TG, where FC is free cholesterol content and CE is cholesteryl ester content] is significantly different from zero (/?=0.03), with the most weight on triglycerides. However, in this case, we observed that the correlation that exists between the canonical variable and the cholesteryl ester content (CE, -0.18) has an opposite sign when compared with that of the coefficient of the variable (CE, +2.68); therefore, cholesteryl ester is a suppressor variable. In practical terms, this means that the higher the levels of free cholesterol, cholesteryl ester, or triglyceride, the less accessible are the epitopes recognized by MAb BAH (as indicated by positive coefficient correlations), but in the combination of the three parameters (free cholesterol, cholesteryl ester, and triglyceride), the higher the levels of cholesteryl ester, the more accessible are the epitopes (as indicated by a negative correlation coefficient), whereas the higher the levels of free cholesterol and triglyceride, the less accessible are the epitopes.
Discussion
In this study, we isolated LDLs with a very large heterogeneity in lipid as well as in apolipoprotein (apo E and apo C-III) composition. We studied the expression of apo B epitopes in each LDL preparation using a large panel of anti-apo B MAbs for which epitopes were previously mapped on the molecule. An extensive statistical analysis permitted the search for a potential relation between LDL chemical composition and alterations in the apo B epitope expression. Besides a schematic model of LDL structure that associates several types of lipids of varying hydrophobicity and of apolipoproteins, 2 there exists a number of LDLs with different conformations related to their metabolic, clinical, nutritional, or pharmacological situations.
7 -9 - 31 It is very important to study the changes that occur in the conformation of the apo B associated with LDL because they may affect the interaction of the lipoproteins with cell-surface LDL receptors. 4 Numerous attempts to determine this structural organization have been largely frustrated because of the extreme insolubility and aggregability of delipidated apo B. More recent investigations have used MAbs to probe the apo B structure in LDLs. A number of these studies have established that apo B is immunochemically heterogeneous and that alterations in the size and/or the chemical components of LDL result in changes in immunoreactivity. However, it is not clear which aspects of lipoprotein structure are responsible for maintaining epitopes in a given conformation. Lipids probably have a very important influence. 9 -' 134 - 36 The expression of some apo B epitopes on LDLs may correlate with the core lipid contents of the particles, 10 ' 32 whereas the expression of others correlate with phospholipid content, i.e., surface lipid components. 10 Also, changes in apo B epitope expression may be due to alterations in both regions of the particles. 410 Another level of complexity also exists, namely, the presence of other apolipoproteins that may interact with apo B and modify epitope expression. 12 -37 - 38 Marcel et al 12 indicated that in some VLDL species, apo E or apo C may mask certain epitopes, such as 1D1, located in the ^/-terminal part of apo B between residues 401 and 582. Very recently, Agnani et al 37 have shown that the presence of apo C-III on apo B-containing particles abolished their binding to the cellular receptors. This confirms the previous result from Ginsberg et al, 38 who had deduced from one in vivo study that apo C-III acts as an inhibitor of LDL binding on its receptor. More recently, Eisenberg and Sehayek 13 have demonstrated that interaction of VLDL or intermediate density lipoprotein with the LDL receptor is inhibited by the C apolipoprotein, apo C-I being the most effective. They also pointed out the importance of the apo E-3/apo C ratio in determining the uptake and degradation of VLDL. The protein moiety is actually thought to have an important role in the formation of epitopes. In this way, Koren et al 39 have described a Cl MAb that is specific for a particular conformation of apo B expressed in lipoprotein particles containing apo B and apo E exclusively as protein components. Finally, in a recent in vivo metabolic study performed with various LDL density subpopulations from subjects with normolipidemia and familial combined hyperlipidemia, it has been suggested that the presence of non-apo B apolipoproteins could influence the metabolic behavior of different LDL subclasses. 40 In summary, many results confirm the importance of the lipid moiety of LDL in maintaining the conformation of apo B, but it is indisputable that the protein moiety also plays an important role in this. Therefore, it is impossible to differentiate between both components, which act in concert to determine apo B antigenic determinants on LDL. This is confirmed by quite different results obtained for the immunoreactivity of LDL in relation to its biochemical composition when we consider lipids and proteins as separate variables (Table  4) or as undissociable variables (Table 5) .
Marcel et al 41 have previously demonstrated the lipid dependence of the major domains of apo B and have shown that, for the expression of certain antigenic determinants, the protein does not have the same complement of lipids. Hence, apo B may show selective differences in reactivity with individual MAbs, depending somewhat on the presence of specific lipids. Whatever the area on the molecule may be, we thereby demonstrate a proper function of lipids in determining the orientation and configuration of apo B in LDL (Table 5) . We also confirm, as already demonstrated, 810 -32 the importance of either surface or core lipids (phospholipids and/or free cholesterol, triglycerides and/or cholesteryl esters, respectively) in such a determination. Tikkanen et al 42 have shown that in some VLDLs, apo B-100 epitope expression was altered by the action of lipoprotein lipase, whereas others were not. Following this example, our study demonstrates that the core lipid content as well as the surface components do not uniformly affect the expression of all epitopes. Thus, since during lipolysis both surface phospholipids and core lipids (triglycerides) are lost, the changes in apo B epitope expression may be due to alterations in both regions of the particle. Therefore, the resulting reorganization of lipoprotein structure may produce changes in apo B disposition.
We also confirm the importance of triglyceride content in the apo B immunoreactivity. This variable appears as a constant canonical one (except for BL7 affinity) with a high weight ( 44 It is interesting to observe a very strong dependence of lipids (as indicated by elevated canonical coefficients) in the determination of immunoreactivity (apparent apo B content and affinity) of the epitopes recognized by MAb BAH that has been previously located in the LDL receptor domain. 25 This result corroborates initial results from Marcel et al, 41 who have shown the requirement of lipids, and more specifically cholesteryl esters, for the expression of epitopes mapped in this region. Our statistical approach permits us to confirm this requirement but only in combination with free cholesterol and triglyceride content. The partial correlations between apolipoproteins and immunochemical parameters that we report in Table 4 are not truly confirmed by canonical analysis, particularly for the apo C-III data. This means that considering LDL in its complex structure, apo C-III, in contrast with apo E, seems not to influence the expression of the apo B epitopes. The results presented here may be in apparent contradiction with those of another group from our lab 37 who observed a different behavior of apo B-containing particles with regard to the LDL-specific receptor pathway when they concomitantly contain apo C-III. One interpretation may be that the binding of a given MAb depends on the specific conformation of a relatively small region of apo B-100 that is more difficult to modify than the LDL receptor recognition domain, but it is certainly more true that alterations of regions at a distance from this specific site may modulate the interactions of apo B-100 with the LDL receptor. 32 It is clear that LDLs are heterogeneous among and within individuals and that several aspects of composition and metabolism may interact to determine the relative atherogenicity of LDLs in each of them. However, the numerous experiments performed to understand the structural relation between lipids and apo B-100 in LDLs and how they affect LDL metabolism are, in our mind, open to discussion. Our present study clearly keeps in mind that all lipid and apolipoprotein parameters are highly associated in LDLs and that they all contribute to maintain the apo B molecule in its spatial disposition.
